Cardiac pumping capability in patients with peripheral vascular disease

被引:2
|
作者
Hodges, LD [1 ]
Sandercock, GRH [1 ]
Das, SK [1 ]
Brodie, DA [1 ]
机构
[1] BCUC, Res Ctr Hlth Studies, Chalfont St Giles HP8 4AD, Bucks, England
关键词
cardiac power output; cardiovascular disease; peripheral vascular disease;
D O I
10.1111/j.1475-097X.2006.00673.x
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
Introduction: Peripheral vascular disease (PVD) is a condition characterized by atherosclerotic occlusive disease of the lower extremities, low functional capacity and low exercise tolerance. Less empirical data are available concerning the cardiovascular response to maximum exercise tests in patients with PVD. The purpose of this study was to examine cardiovascular variables in patients with peripheral vascular disease. Methods: Fifty patients (67 +/- 9 years) completed an incremental exercise test (2 min stages, 3.2 km h(-1), with increases of 2% every 2 min) to maximum claudication pain. Maximal oxygen consumption (Vo(2peak)) was assessed on a breath-by-breath basis by online expiratory gas analysis (CardiO(2), Medical Graphics Co.). Blood pressure was recorded at peak exercise. Following a 30-min rest period, patients exercised at the highest level attained during the first test and cardiac output (QT) was measured using the exponential non-invasive rebreathing method. Cardiac power output peak (CPOpeak) in Watts (W), was then computed. Results: Mean +/- SD values were; VO2peak 13.85 +/- 4.14 ml kg min(-1); maximal walk time 357 +/- 227 s; peak mean arterial pressure 127 +/- 15 mmHg; QT 9.8 +/- 2.39 (l min(-1)); CPO 2.86 +/- 0.87 W. Conclusions: Patients with peripheral vascular disease demonstrate attenuated levels of cardiovascular capacity. This group of patients should be given exercise therapy in order to improve cardiovascular status and ambulatory function.
引用
收藏
页码:185 / 190
页数:6
相关论文
共 50 条
  • [21] Nitrotyrosine in peripheral vascular disease
    Da Ros, R
    Quagliaro, L
    Gasparini, D
    Barillari, G
    Ceriello, A
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2003, 1 (02) : 382 - 383
  • [22] Diabetes Mellitus and Peripheral Vascular Disease Diagnosis and Management
    Chin, Jason A.
    Sumpio, Bauer E.
    CLINICS IN PODIATRIC MEDICINE AND SURGERY, 2014, 31 (01) : 11 - +
  • [23] Adipokine Imbalance in the Pericardial Cavity of Cardiac and Vascular Disease Patients
    Elie, Atlanta G. I. M.
    Jensen, Pia S.
    Nissen, Katrine D.
    Geraets, Ilvy M. E.
    Xu, Aimin
    Song, Erfei
    Hansen, Maria L.
    Irmukhamedov, Akhmadjon
    Rasmussen, Lars M.
    Wang, Yu
    De Mey, Jo G. R.
    PLOS ONE, 2016, 11 (05):
  • [24] A systematic review of the incidence and prevalence of cardiac, cerebrovascular, and peripheral vascular disease in multiple sclerosis
    Marrie, Ruth Ann
    Reider, Nadia
    Cohen, Jeffrey
    Stuve, Olaf
    Trojano, Maria
    Cutter, Gary
    Reingold, Stephen
    Sorensen, Per Soelberg
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (03) : 318 - 331
  • [25] The Vascular and Biochemical Effects of Cilostazol in Diabetic Patients With Peripheral Arterial Disease
    O'Donnell, Mark E.
    Badger, Stephen A.
    Sharif, Muhammad A.
    Makar, Ragai R.
    Young, Ian S.
    Lee, Bernard
    Soong, C. V.
    VASCULAR AND ENDOVASCULAR SURGERY, 2009, 43 (02) : 132 - 143
  • [26] PATTERN OF VASCULAR INVOLVEMENT IN PATIENTS WITH LOWER EXTREMITY PERIPHERAL ARTERIAL DISEASE
    Kumar, Mukesh
    Khan, Naveedullah
    Jalbani, Javed
    Shar, Ghulam Shabbir
    Ishaq, Haroon
    Shaikh, Abdul Hakeem
    PAKISTAN HEART JOURNAL, 2022, 55 (02): : 166 - 170
  • [27] Prevalence of metabolic syndrome in patients with clinically advanced peripheral vascular disease
    Qadan, Laila R.
    Ahmed, Adel A.
    Safar, Hussein A.
    Al-Bader, Marzouk A.
    Ali, Amr A.
    ANGIOLOGY, 2008, 59 (02) : 198 - 202
  • [28] Metabolic syndrome and vascular risk in patients with peripheral arterial occlusive disease
    Vlek, Anne L. M.
    van der Graaf, Yolanda
    Sluman, Maayke A.
    Moll, Frans L.
    Visseren, Frank L. J.
    JOURNAL OF VASCULAR SURGERY, 2009, 50 (01) : 61 - 69
  • [29] RATIONALE FOR THE USE OF ANTIPLATELET DRUGS IN PATIENTS WITH PERIPHERAL VASCULAR-DISEASE
    VIOLI, F
    BALSANO, F
    CLINICAL TRIALS AND META-ANALYSIS, 1994, 29 (01) : 81 - 87
  • [30] Use of antiplatelets and lipid lowering therapy in patients with peripheral vascular disease
    Aldawood, AS
    Jaeschke, R
    SAUDI MEDICAL JOURNAL, 2002, 23 (05) : 585 - 588